Potassium channel openers as potential therapeutic weapons in ion channel disease

Kidney International

Volumn 57, Issue 3, 2000, Pages 838-845

  Lawson, Kim ^a  

^a SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

Equilibrium potential; Extracellular membrane; Hyperpolarization; Synthetic KCOs; Transmembrane ions

Indexed keywords

1 (5 CHLORO 2 HYDROXYPHENYL) 5 TRIFLUOROMETHYL 2 BENZIMIDAZOLONE; 3,4 DIHYDRO 2,2 DIMETHYL 4 (2 OXO 1 PIPERIDINYL) 6 PENTAFLUOROETHYL 2H 1 BENZOPYRAN 3 OL; APRIKALIM; CROMAKALIM; DIAZOXIDE; DIHYDROPYRIDINE DERIVATIVE; FENAMIC ACID DERIVATIVE; ION CHANNEL; MAXIKDIOL; MINOXIDIL SULFATE; N (4 BENZOYLPHENYL) 3,3,3 TRIFLUORO 2 HYDROXY 2 METHYLPROPIONAMIDE; NICORANDIL; NIFLUMIC ACID; NITRENDIPINE; PHLORETIN; PINACIDIL; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; SULFONYLUREA RECEPTOR; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DRUG EFFECT; DRUG SAFETY; DRUG SCREENING; DRUG STRUCTURE; HUMAN; ION CURRENT; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0033945753     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00923.x     Document Type: Conference Paper

References (28)

1. LAWSON K: Potassium channel activation: A potential therapeutic approach? Pliarmacol Tlier 70:39-63, 1996
2. STARRETT JE, DWORETZKY SI, GRIBKOFF VK: Modulators of largeconductance calcium-activated potassium channels as potential therapeutic targets. Curr Pliarm Design 2:413-428, 1996
3. + channels in the cardiovascular system. J Cardiovasc Elcctrophysiol 8:1431-1446, 1997
4. + channels in pancreatic, cardiac, and vascular smooth muscle cells. Am J Pliysiol 274(Cell Physiol 43):C25-C37, 199S
5. KACZOROWSKI GJ, KNAUS H-G, LEONARD RJ, McM.\NUS OB, GARCIA ML: High-conductance calcium-activated potassium channels; structure, pharmacology and function. J Bioenerg Biomembr 28:255-267, 1995
6. FURUKAWA K, ITOII T, KAJIWARA M, KITAMURA K, SUZUKI H, ITO Y, KURIYAMA H: Vasodilating actions of 2-nicotinamidoethyl nitrate on porcine and guinea-pig coronary arteries. J Pliarmacol Exp Ther 218:248-259, 1981
7. ITOII T, FURUKAWA K, KAJIWARA M, KITAMURA K, SUZUKI H, ITO Y, KURIYAMA H: Effects of 2-nicotinamidoethyl nitrate on smooth muscle cells and on adrenergic transmission in the guinea-pig and porcine mesenteric arteries. J Pharmacol Exp Ther 218:260-270, 1981
8. HOLZMANN S: Cyclic GMP as a possible mediator of coronary arterial relaxation by nicorandil (SG-75). J Cardiovasc Pharmacol 5:364-370, 1983
9. HAMILTON TC, WEIR SW, WESTON AH: Comparison of the effects of cromakalim and verapamil on electrical and mechanical activity in rat portal vein. Br J Pharmacol 88:103-111, 1986
10. HAMILTON TC, WESTON AH: Cromakalim, nicorandil and pinacidil: Novel drugs which open potassium channels in smooth muscle. Gen Pharmacol 20:1-9, 19S9
11. + channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandil. EurJ Pharmacol 152:331-339, 1988
12. EDWARDS O, WESTON AH: The pharmacology of ATP-sensitive potassium channels. Aiinii Rev Pharmacol Toxicol 33:597-637, 1993
13. ATWAL KS: Pharmacology and structure-activity relationships for KATP modulators: Tissue-selective KATP openers. J Cardiovasc Pliarmacol 24(Suppl):S12-S17, 1994
14. + channel openers by pharmacophore model. Bioorg Med Cliem Lett 3:625-631, 1993
15. WELLMAN GC, QUAYLE JM: ATP-sensitive potassium channels: Molecular structure and therapeutic potential in smooth muscle. Ion Channel Modulators ID Res Alerts 2:75-83, 1997
16. HIRATA Y, AISAKA K: Effect of JTV-506, a novel vasodilator on coronary blood flow in conscious dogs. / Cardiovnsc Phannacol 29:397-405, 1997
17. AGUILAR-BRYAN L, NICHOLS CG, WECHESLER SW, CLEMENT JP, BOYD AE, GONZALEZ G, HERRERA-SOSA H, NGUY K, BRYAN J, NELSON DA: Cloning of the cell high-affinity sulphonylurea receptor: A regulator of insulin secretion. Science 268:423-426,1995
18. + channels. Neuron 16:1011-1017, 1996
19. CIIUTKOW \VA, SIMON MC, LE BEAU MM, BURANT CF: Cloning, tissue expression and chromosomal localization of SUR2, the putative drug-binding subunit of cardiac, skeletal muscle and vascular KATP channels. Diabetes 455:1439-1445, 1996
20. äMMäLä C, MOORIIOUSE A, GRIBBLE FM, ASIIFIELD P, PROKS P, SMITH PA, SAKURA H, COLES B, ASHCROFT SJH, ASIICROFT FM: Promiscuous coupling between the sulphonylurea receptor and inwardly rectifying potassium channels. Nature 379:545-548, 1996
21. LATORRE R, OBERHAUSER A, LABARCA P, ALVAREZ O: Varieties of calcium-activated potassium channels. Anna Rev Pliysiol 51:385399, 1989
22. BRAYDEN JE, NELSON MT: Regulation of arterial tone by activation of calcium-dependent potassium channels. Science 256:532-535, 1992
23. McMANUS OB: Calcium-activated potassium channels - regulation by calcium. J Bioenerg Biomembr 23:537-560, 1991
24. + channels. Exp Opin Invest Drugs 3:1181-1188, 1994
25. + channels by novel benzimidazolone. EurJ Pharmacol 251:53-59, 1994
26. GARCIA-CALVO M, KNAUS H-G, MCMANUS OB, GIANGIACOMO KM, KACZOROWSKI GJ, GARCIA ML: Purification and reconstitution of the high-conductance, calcium-activated potassium channel from trachéal smooth muscle. J Biol Cliem 269:676-682, 1994
27. KNAUS H-G, GARCIA-CALVO M, KACZOROWSKI GJ, GARCIA ML: Subunit composition of the high-conductance, calcium activated potassium channel from smooth muscle, a representative of the inSlo and slowpoke family of potassium channels. J Biol Cliein 29:3921-3924, 1994
28. MCMANUS OB, HELMS LMH, PALLANCK L, GANETZKV B, SWANSON R, LEONARD RJ: Functional role of the -subunit of high-conductance calcium-activated potassium channels. Neuron 14:645-650, 1995